Research shows that nuclear receptor subfamily 2 group F member 6 (NR2F6) promotes MASLD by activating CD36 gene expression, inducing TG retention, and providing a new molecular basis for hepatic steatosis [109]. Here, NR2F6 is linked to fatty liver disease.